Nefiracetam elevates extracellular acetylcholine level in the frontal cortex of rats with cerebral cholinergic dysfunctions: An in vivo microdialysis study

Takeo Sakurai, Takeshi Kato, Kumiko Mori, Emi Takano, Shigeo Watabe, Toshitaka Nabeshima

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

We determined the effect of nefiracetam, a novel cognitive enhancer, on the extracellular acetylcholine (ACh) level in the frontal cortex of freely moving rats, using a microdialysis technique without an acetylcholinesterase inhibitor in the perfusate. Treatment with nefiracetam (10 mg/kg, p.o.) produced a significant increase in the level of ACh in the brain dialysate, compared with the vehicle-treated group. This enhancing effect was also observed when the ACh level was elevated by administration of scopolamine (1 mg/kg, i.p.) at 45 min after the treatment with nefiracetam. In addition, perfusion of nefiracetam at the concentration of 10 μM significantly increased the extracellular ACh level in the frontal cortex of basal forebrain (BF)-lesioned rats, in which a marked decrease of the basal ACh level was observed in this region. These results suggest that enhancement of cortical ACh release by nefiracetam may contribute to an anti-amnesic effect on the learning deficits induced by treatment of scopolamine or BF-lesion in rats.

Original languageEnglish
Pages (from-to)69-72
Number of pages4
JournalNeuroscience Letters
Volume246
Issue number2
DOIs
Publication statusPublished - 24-04-1998
Externally publishedYes

Fingerprint

Microdialysis
Frontal Lobe
Cholinergic Agents
Acetylcholine
Scopolamine Hydrobromide
Nootropic Agents
Dialysis Solutions
Cholinesterase Inhibitors
nefiracetam
Therapeutics
Perfusion
Learning
Brain

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)

Cite this

@article{c02a0596d17142458e9ed70c2dda366e,
title = "Nefiracetam elevates extracellular acetylcholine level in the frontal cortex of rats with cerebral cholinergic dysfunctions: An in vivo microdialysis study",
abstract = "We determined the effect of nefiracetam, a novel cognitive enhancer, on the extracellular acetylcholine (ACh) level in the frontal cortex of freely moving rats, using a microdialysis technique without an acetylcholinesterase inhibitor in the perfusate. Treatment with nefiracetam (10 mg/kg, p.o.) produced a significant increase in the level of ACh in the brain dialysate, compared with the vehicle-treated group. This enhancing effect was also observed when the ACh level was elevated by administration of scopolamine (1 mg/kg, i.p.) at 45 min after the treatment with nefiracetam. In addition, perfusion of nefiracetam at the concentration of 10 μM significantly increased the extracellular ACh level in the frontal cortex of basal forebrain (BF)-lesioned rats, in which a marked decrease of the basal ACh level was observed in this region. These results suggest that enhancement of cortical ACh release by nefiracetam may contribute to an anti-amnesic effect on the learning deficits induced by treatment of scopolamine or BF-lesion in rats.",
author = "Takeo Sakurai and Takeshi Kato and Kumiko Mori and Emi Takano and Shigeo Watabe and Toshitaka Nabeshima",
year = "1998",
month = "4",
day = "24",
doi = "10.1016/S0304-3940(98)00244-4",
language = "English",
volume = "246",
pages = "69--72",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

Nefiracetam elevates extracellular acetylcholine level in the frontal cortex of rats with cerebral cholinergic dysfunctions : An in vivo microdialysis study. / Sakurai, Takeo; Kato, Takeshi; Mori, Kumiko; Takano, Emi; Watabe, Shigeo; Nabeshima, Toshitaka.

In: Neuroscience Letters, Vol. 246, No. 2, 24.04.1998, p. 69-72.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Nefiracetam elevates extracellular acetylcholine level in the frontal cortex of rats with cerebral cholinergic dysfunctions

T2 - An in vivo microdialysis study

AU - Sakurai, Takeo

AU - Kato, Takeshi

AU - Mori, Kumiko

AU - Takano, Emi

AU - Watabe, Shigeo

AU - Nabeshima, Toshitaka

PY - 1998/4/24

Y1 - 1998/4/24

N2 - We determined the effect of nefiracetam, a novel cognitive enhancer, on the extracellular acetylcholine (ACh) level in the frontal cortex of freely moving rats, using a microdialysis technique without an acetylcholinesterase inhibitor in the perfusate. Treatment with nefiracetam (10 mg/kg, p.o.) produced a significant increase in the level of ACh in the brain dialysate, compared with the vehicle-treated group. This enhancing effect was also observed when the ACh level was elevated by administration of scopolamine (1 mg/kg, i.p.) at 45 min after the treatment with nefiracetam. In addition, perfusion of nefiracetam at the concentration of 10 μM significantly increased the extracellular ACh level in the frontal cortex of basal forebrain (BF)-lesioned rats, in which a marked decrease of the basal ACh level was observed in this region. These results suggest that enhancement of cortical ACh release by nefiracetam may contribute to an anti-amnesic effect on the learning deficits induced by treatment of scopolamine or BF-lesion in rats.

AB - We determined the effect of nefiracetam, a novel cognitive enhancer, on the extracellular acetylcholine (ACh) level in the frontal cortex of freely moving rats, using a microdialysis technique without an acetylcholinesterase inhibitor in the perfusate. Treatment with nefiracetam (10 mg/kg, p.o.) produced a significant increase in the level of ACh in the brain dialysate, compared with the vehicle-treated group. This enhancing effect was also observed when the ACh level was elevated by administration of scopolamine (1 mg/kg, i.p.) at 45 min after the treatment with nefiracetam. In addition, perfusion of nefiracetam at the concentration of 10 μM significantly increased the extracellular ACh level in the frontal cortex of basal forebrain (BF)-lesioned rats, in which a marked decrease of the basal ACh level was observed in this region. These results suggest that enhancement of cortical ACh release by nefiracetam may contribute to an anti-amnesic effect on the learning deficits induced by treatment of scopolamine or BF-lesion in rats.

UR - http://www.scopus.com/inward/record.url?scp=0032562553&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032562553&partnerID=8YFLogxK

U2 - 10.1016/S0304-3940(98)00244-4

DO - 10.1016/S0304-3940(98)00244-4

M3 - Article

C2 - 9627182

AN - SCOPUS:0032562553

VL - 246

SP - 69

EP - 72

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 2

ER -